申请人:Abbott Laboratories
公开号:US05432194A1
公开(公告)日:1995-07-11
Compounds of the structure ##STR1## wherein W is selected from ##STR2## where Q is oxygen or sulfur, R.sup.6 and R.sup.7 are hydrogen or alkyl, or R.sup.6 and R.sup.7, together with the nitrogen atoms to which they are attached, define a radical of formula ##STR3## R.sup.8 is selected from hydrogen, alkyl, haloalkyl, optionally substituted phenyl, hydroxyalkyl, aminoalkyl, carboxyalkyl, (alkoxycarbonyl)alkyl, and (alkylaminocarbonyl)alkyl; Z is --CH.sub.2 --, oxygen, sulfur, or --NR.sup.9 where R.sup.9 is hydrogen or alkyl, L.sup.1 and L.sup.2 are selected from a valence bond, alkylene, propenylene, and propynylene, R.sup.1, R.sup.2, R.sup.3, and R.sup.4 are independently selected from alkyl, haloalkyl, halogen, cyano, amino, alkoxycarbonyl, and dialkylaminocarbonyl, Y is selected from oxygen, --NR.sup.10, where R.sup.10 is hydrogen or alkyl, and ##STR4## where n=0, 1, or 2, and R.sup.5 is alkyl, inhibit the biosynthesis of leukotrienes. These compounds are useful in the treatment or amelioration of allergic and inflammatory disease states.
结构为##STR1##的化合物,其中W从##STR2##中选择,其中Q为氧或硫,R.sup.6和R.sup.7为氢或烷基,或者R.sup.6和R.sup.7与它们连接的氮原子一起定义为##STR3##的基团,R.sup.8从氢、烷基、卤代烷基、可选择取代的苯基、羟基烷基、氨基烷基、羧基烷基、(烷氧羰基)烷基和(烷基氨基羰基)烷基中选择;Z为--CH.sub.2 --、氧、硫或--NR.sup.9,其中R.sup.9为氢或烷基,L.sup.1和L.sup.2从价键、烷基、丙烯基和丙炔基中选择,R.sup.1、R.sup.2、R.sup.3和R.sup.4分别从烷基、卤代烷基、卤素、氰基、氨基、烷氧羰基和二烷基氨基羰基中独立选择,Y从氧、--NR.sup.10中选择,其中R.sup.10为氢或烷基,以及##STR4##其中n=0、1或2,R.sup.5为烷基,抑制白三烯的生物合成。这些化合物在治疗或缓解过敏和炎症性疾病状态中很有用。